These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 1895409)

  • 1. Substrate specificity of recombinant human immunodeficiency virus integrase protein.
    LaFemina RL; Callahan PL; Cordingley MG
    J Virol; 1991 Oct; 65(10):5624-30. PubMed ID: 1895409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration.
    Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
    Arch Biochem Biophys; 1993 Feb; 300(2):756-60. PubMed ID: 8434953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.
    Leavitt AD; Rose RB; Varmus HE
    J Virol; 1992 Apr; 66(4):2359-68. PubMed ID: 1548767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation analysis, and by swapping the zinc finger domain of HIV-1.
    Pahl A; Flügel RM
    J Biol Chem; 1995 Feb; 270(7):2957-66. PubMed ID: 7852375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-terminal region of HIV-1 integrase is required for integration activity, but not for DNA-binding.
    Schauer M; Billich A
    Biochem Biophys Res Commun; 1992 Jun; 185(3):874-80. PubMed ID: 1627142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction.
    Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
    Biochem Biophys Res Commun; 1993 May; 192(3):1409-14. PubMed ID: 8389550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage.
    Vink C; van Gent DC; Elgersma Y; Plasterk RH
    J Virol; 1991 Sep; 65(9):4636-44. PubMed ID: 1870194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity.
    Sherman PA; Fyfe JA
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5119-23. PubMed ID: 2164223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metal ion-induced cooperative binding of HIV-1 integrase to DNA exhibits a marked preference for Mn(II) rather than Mg(II).
    Pemberton IK; Buckle M; Buc H
    J Biol Chem; 1996 Jan; 271(3):1498-506. PubMed ID: 8576144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved residues Pro-109 and Asp-116 are required for interaction of the human immunodeficiency virus type 1 integrase protein with its viral DNA substrate.
    Drelich M; Haenggi M; Mous J
    J Virol; 1993 Aug; 67(8):5041-4. PubMed ID: 8392628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration.
    Reicin AS; Kalpana G; Paik S; Marmon S; Goff S
    J Virol; 1995 Sep; 69(9):5904-7. PubMed ID: 7637038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells.
    LaFemina RL; Schneider CL; Robbins HL; Callahan PL; LeGrow K; Roth E; Schleif WA; Emini EA
    J Virol; 1992 Dec; 66(12):7414-9. PubMed ID: 1433523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations.
    Vincent KA; Ellison V; Chow SA; Brown PO
    J Virol; 1993 Jan; 67(1):425-37. PubMed ID: 8416376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction.
    Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
    Arch Biochem Biophys; 1993 Sep; 305(2):606-10. PubMed ID: 8373200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
    Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases.
    Katzman M; Sudol M
    J Virol; 1995 Sep; 69(9):5687-96. PubMed ID: 7637015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endonucleolytic cleavages and DNA-joining activities of the integration protein of human foamy virus.
    Pahl A; Flügel RM
    J Virol; 1993 Sep; 67(9):5426-34. PubMed ID: 7688824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 integrase stabilizes a linearized HIV-1 LTR plasmid in vivo.
    Faust EA; Acel A; Udashkin B; Wainberg MA
    Biochem Mol Biol Int; 1995 Jul; 36(4):745-58. PubMed ID: 8528137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of recombinant HIV-1 integrase on mini-HIV DNA.
    Cherepanov P; Surratt D; Toelen J; Pluymers W; Griffith J; De Clercq E; Debyser Z
    Nucleic Acids Res; 1999 May; 27(10):2202-10. PubMed ID: 10219094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions.
    Sherman PA; Dickson ML; Fyfe JA
    J Virol; 1992 Jun; 66(6):3593-601. PubMed ID: 1374809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.